In this study we have combined data from a population-based series of breast cancer cases with data from high risk families, to investigate the genetic models that can explain familial breast cancer outside BRCA1 and BRCA2 families, and evaluate the evidence for risk modifiers in BRCA1 and BRCA2 mutation carriers. The gene discussed is BRCA1; the disease is breast cancer.